During the past decade, Atlanta Center for Medical Research conducted 133 clinical trials. In the 10-year time frame, 133 clinical trials started and 109 clinical trials were completed, i.e. on average, 82% percent of trials that started reached the finish line to date. In the past 5 years, 42 clinical trials started and 63 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Atlanta Center for Medical Research" #1 sponsor was "Pfizer" with 29 trials, followed by "Sunovion" with 29 trials sponsored, "Eli Lilly and Company" with 12 trials sponsored, "Shire" with 9 trials sponsored and "Janssen Research & Development, LLC" with 9 trials sponsored. Other sponsors include 126 different institutions and companies that sponsored additional 80 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Atlanta Center for Medical Research" #1 collaborator was "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 2 trials as a collaborator, "National Institute on Aging (NIA)" with 2 trials as a collaborator and "Pfizer" with 2 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Atlanta Center for Medical Research" are "Schizophrenia" (39 trials), "Major Depressive Disorder" (25 trials), "Depressive Disorder, Major" (12 trials), "Alzheimer's Disease" (10 trials) and "Alzheimer Disease" (8 trials). Many other conditions were trialed in "Atlanta Center for Medical Research" in a lesser frequency.

Most popular intervention types in "Atlanta Center for Medical Research" are "Drug" (198 trials), "Other" (23 trials), "Biological" (16 trials), "Device" (4 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (116 trials), "placebo" (12 trials), "Lurasidone" (9 trials), "Rapastinel" (5 trials) and "Dasotraline" (4 trials). Other intervention names were less common.

The vast majority of trials in "Atlanta Center for Medical Research" are 214 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Atlanta Center for Medical Research". undefined are not yet recruiting, 15 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 158 completed trials in Atlanta Center for Medical Research, 1 suspended trials, and 35 terminated clinical trials to date.

Out of the total trials that were conducted in Atlanta Center for Medical Research, 28 "Phase 1" clinical trials were conducted, 82 "Phase 2" clinical trials and 106 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 5 trials that are defined as “Not Applicable".